All Terrain Financial Advisors’s Amgen AMGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $1.99M | Sell |
5,661
-452
| -7% | -$161K | 0.47% | 38 |
|
|
2025
Q4 | $2M | Buy |
6,113
+522
| +9% | +$166K | 0.46% | 40 |
|
|
2025
Q3 | $1.58M | Sell |
5,591
-1,411
| -20% | -$409K | 0.39% | 51 |
|
|
2025
Q2 | $1.95M | Buy |
7,002
+3
| +0% | +$850 | 0.56% | 32 |
|
|
2025
Q1 | $2.18M | Buy |
6,999
+426
| +6% | +$126K | 0.69% | 28 |
|
|
2024
Q4 | $1.71M | Buy |
6,573
+192
| +3% | +$57K | 0.56% | 33 |
|
|
2024
Q3 | $2.06M | Sell |
6,381
-16
| -0.3% | -$5.23K | 0.75% | 30 |
|
|
2024
Q2 | $2M | Buy |
6,397
+93
| +1% | +$27.3K | 0.79% | 28 |
|
|
2024
Q1 | $1.79M | Sell |
6,304
-3
| -0% | -$878 | 0.7% | 31 |
|
|
2023
Q4 | $1.82M | Buy |
6,307
+56
| +0.9% | +$15.3K | 0.69% | 30 |
|
|
2023
Q3 | $1.68M | Buy |
6,251
+57
| +0.9% | +$14.2K | 0.71% | 31 |
|
|
2023
Q2 | $1.38M | Buy |
6,194
+548
| +10% | +$127K | 0.52% | 38 |
|
|
2023
Q1 | $1.36M | Buy |
5,646
+44
| +0.8% | +$10.8K | 0.56% | 38 |
|
|
2022
Q4 | $1.47M | Buy |
5,602
+78
| +1% | +$20.9K | 0.65% | 34 |
|
|
2022
Q3 | $1.25M | Buy |
5,524
+21
| +0.4% | +$5.09K | 0.54% | 34 |
|
|
2022
Q2 | $1.34M | Sell |
5,503
-410
| -7% | -$100K | 0.57% | 35 |
|
|
2022
Q1 | $1.43M | Sell |
5,913
-225
| -4% | -$51.7K | 0.58% | 36 |
|
|
2021
Q4 | $1.38M | Sell |
6,138
-4
| -0.1% | -$844 | 0.56% | 34 |
|
|
2021
Q3 | $1.31M | Sell |
6,142
-31
| -0.5% | -$7.13K | 0.57% | 35 |
|
|
2021
Q2 | $1.5M | Sell |
6,173
-180
| -3% | -$44.3K | 0.69% | 35 |
|
|
2021
Q1 | $1.58M | Buy |
6,353
+60
| +1% | +$14.3K | 0.72% | 35 |
|
|
2020
Q4 | $1.45M | Buy |
6,293
+379
| +6% | +$87.4K | 0.57% | 32 |
|
|
2020
Q3 | $1.5M | Buy |
5,914
+65
| +1% | +$16.1K | 0.51% | 37 |
|
|
2020
Q2 | $1.38M | Sell |
5,849
-185
| -3% | -$42.2K | 0.57% | 39 |
|
|
2020
Q1 | $1.22M | Sell |
6,034
-11
| -0.2% | -$2.4K | 0.5% | 43 |
|
|
2019
Q4 | $1.46M | Sell |
6,045
-53
| -0.9% | -$11.7K | 0.47% | 42 |
|
|
2019
Q3 | $1.18M | Sell |
6,098
-396
| -6% | -$76K | 0.4% | 44 |
|
|
2019
Q2 | $1.2M | Buy |
6,494
+5
| +0.1% | +$895 | 0.41% | 45 |
|
|
2019
Q1 | $1.23M | Sell |
6,489
-270
| -4% | -$51.6K | 0.43% | 43 |
|
|
2018
Q4 | $1.32M | Buy |
6,759
+19
| +0.3% | +$3.71K | 0.52% | 38 |
|
|
2018
Q3 | $1.4M | Sell |
6,740
-6
| -0.1% | -$1.18K | 0.57% | 38 |
|
|
2018
Q2 | $1.25M | Buy |
6,746
+326
| +5% | +$57.7K | 0.56% | 39 |
|
|
2018
Q1 | $1.09M | Buy |
6,420
+155
| +2% | +$28.5K | 0.5% | 46 |
|
|
2017
Q4 | $1.09M | Buy |
+6,265
| New | +$1.11M | 0.5% | 47 |
|
Other funds holding AMGN
VCM
VPM
All Terrain Financial Advisors's AMGN Position: Q1 2026 in Review
All Terrain Financial Advisors reduced its Amgen (AMGN) stake by 7.4% in Q1 2026, selling an estimated $161K and leaving 5,661 shares worth $1.99M. The position accounts for 0.47% of the portfolio, ranked #38.
All Terrain Financial Advisors first reported a position in AMGN in Q4 2017 and has held it in 34 quarters since. The position peaked at $2.18M in Q1 2025. 3,127 funds tracked by Wall St. Rank hold AMGN as of Q1 2026.
- All Terrain Financial Advisors held 5,661 shares of Amgen worth $1.99M as of Q1 2026.
- All Terrain Financial Advisors sold 452 Amgen shares in Q1 2026, an estimated $161K.
- Amgen made up 0.47% of All Terrain Financial Advisors's portfolio in Q1 2026, its #38 holding.
- All Terrain Financial Advisors first reported a position in Amgen in Q4 2017 and has held it in 34 quarters since.
- All Terrain Financial Advisors's Amgen position peaked at $2.18M in Q1 2025.
- 3,127 funds tracked by Wall St. Rank held Amgen as of Q1 2026.
Based on All Terrain Financial Advisors's 13F filing for Q1 2026, filed 12 May 2026.